54% of Kiwis with inflammatory bowel disease would use cannabis if legal

Publicly released:
New Zealand
<span>Photo by <a href="https://unsplash.com/@fortheloveofsmoke?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText">Jeff W</a> on <a href="https://unsplash.com/s/photos/cannabis?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText">Unsplash</a></span>
<span>Photo by <a href="https://unsplash.com/@fortheloveofsmoke?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText">Jeff W</a> on <a href="https://unsplash.com/s/photos/cannabis?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText">Unsplash</a></span>

More than half of Kiwis affected by Inflammatory Bowel Disease (IBD) would use cannabis to help manage their symptoms if it were legal, according to a survey carried out by University of Otago researchers. Of those people surveyed who had used cannabis, 74 per cent reported an improvement in quality of life, and 96 per cent of cannabis users stating that it was effective or very effective at relieving their abdominal pain. The researchers suggest further studies are needed on the safety and usefulness of cannabis to relieve IBD symptoms, and say that it's important for medical practitioners to be able to answer patients' questions on cannabis products.

Media release

From:

Journal/
conference:
New Zealand Medical Journal
Organisation/s: University of Otago
Funder: N/A
Media Contact/s
Contact details are only visible to registered journalists.